Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2190915 in Moderate to Severe Asthma with Elevated Sputum Neutrophils
NCT00850642Phase 2Terminated
- Sponsor
- GSK
- Start
- Jun 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of fiboflapon in asthma, sponsored by GSK. Started Jun 2009; status: terminated.
02
Drugs
fiboflapon
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00850642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00850642.